Waldencast Acquisition Corp
Prices are adjusted according to historical splits.
- Today's Low:
- Today's High:
- Open Price:
- 52W Low:
- 52W High:
- Prev. Close:
- Market Cap.:
- $366.38 million
- Book Value:
- Revenue TTM:
- Operating Margin TTM:
- Gross Profit TTM:
- Profit Margin:
- Return on Assets TTM:
- Return on Equity TTM:
Waldencast Acquisition Corp had its IPO on 2021-05-11 under the ticker symbol WALDW.
The company operates in the Technology sector and Software-Application industry. Waldencast Acquisition Corp has a staff strength of 0 employees.
Shares of Waldencast Acquisition Corp opened at $1 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $0.62 - $1, and closed at $0.62.
This is a -20.92% slip from the previous day's closing price.
A total volume of 479 shares were traded at the close of the day’s session.
In the last one week, shares of Waldencast Acquisition Corp have slipped by -27.06%.
Waldencast Acquisition Corp's Key Ratios
Waldencast Acquisition Corp has a market cap of $366.38 million, indicating a price to book ratio of 0 and a price to sales ratio of 0.
In the last 12-months Waldencast Acquisition Corp’s revenue was $0 with a gross profit of $0 and an EBITDA of $0. The EBITDA ratio measures Waldencast Acquisition Corp's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Waldencast Acquisition Corp’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 0%.
In Q2, Waldencast Acquisition Corp’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.
Waldencast Acquisition Corp’s PE and PEG Ratio
- Forward PE
- Trailing PE
Its diluted EPS in the last 12-months stands at $0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Waldencast Acquisition Corp’s profitability.
Waldencast Acquisition Corp stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.
Waldencast Acquisition Corp stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $345.70 million
- Total Liabilities
- $1.19 million
- Operating Cash Flow
- Capital Expenditure
- Dividend Payout Ratio
Waldencast Acquisition Corp ended 2023 with $345.70 million in total assets and $0 in total liabilities. Its intangible assets were valued at $345.70 million while shareholder equity stood at $295.98 million.
Waldencast Acquisition Corp ended 2023 with $0 in deferred long-term liabilities, $1.19 million in other current liabilities, 345313655.00 in common stock, $-49332716.00 in retained earnings and $0 in goodwill. Its cash balance stood at $99727.00 and cash and short-term investments were $99727.00. The company’s total short-term debt was $0 while long-term debt stood at $2.10 million.
Waldencast Acquisition Corp’s total current assets stands at $382700.00 while long-term investments were $0 and short-term investments were $0. Its net receivables were $0 compared to accounts payable of $1.04 million and inventory worth $0.
In 2023, Waldencast Acquisition Corp's operating cash flow was $0 while its capital expenditure stood at $0.
Comparatively, Waldencast Acquisition Corp paid $0 in dividends in 2023.
Other key metrics
- Current Trading Price
- 52-Week High
- 52-Week Low
- Analyst Target Price
Waldencast Acquisition Corp stock is currently trading at $0.62 per share. It touched a 52-week high of $1.11 and a 52-week low of $1.11. Analysts tracking the stock have a 12-month average target price of $.
Its 50-day moving average was $0.6 and 200-day moving average was $0.6 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 0% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About Waldencast Acquisition Corp
Similar Industry Stocks (Software-Application)
Waldencast Acquisition Corp. a skin care company, provides advanced skin care treatments. Its products are designed to help minimize the appearance of premature skin aging, skin damage, hyperpigmentation, acne, and sun damage primarily available through dermatologists, plastic surgeons, medical spas, and other skin care professionals. Its portfolio includes Obagi Medical that provides transformational skin care products formulated to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines, and wrinkles and to protect and enhance skin tone and texture; and Obagi Clinical that offers skin care products designed to prevent the early signs of skin aging. The company was founded in 1988 and is based in White Plains, New York.